Studies compared Abraxane with solvent-based paclitaxel that is used to treat metastatic breast cancer (cancer that has spread to other parts of the body). Up to 21.5 percent of people taking Abraxane showed improvement in their tumors, compared to just 11.1 percent of those taking solvent-based paclitaxel. Additionally, Abraxane injections were given over just 30 minutes, compared to three hours for solvent-based paclitaxel injections.
Similar results were seen in results of Abraxane for non-small cell lung cancer, with more people responding to Abraxane, compared to solvent-based paclitaxel.
General considerations for when and how to take the medication include the following:
- It is given through an IV.
- Most people receive their injection at their healthcare provider's office, a hospital, or at an "infusion center."
- For the medication to work properly, it must be taken as prescribed. Abraxane will not work as well if you stop taking it before your healthcare provider recommends.
The dose of Abraxane that your healthcare provider recommends will vary depending on a number of factors, including:
- Your height and weight
- The type of cancer
- Other medications you may be taking
- Other medical conditions you may have.
As with any medication, do not adjust your dose unless your healthcare provider specifically instructs you to do so.
(Click Abraxane Dosage for more information.)